Clinical Trials
5 trialsNCT01165333 2026-03-16
CILENT
Centre Oscar Lambret
Phase 1 Completed
NCT00884598 2024-05-10
CIRAB
Universitätsmedizin Mannheim
Phase 1 Completed
NCT01122888 2015-04-28
Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00979862 2015-04-15
Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00063973 2013-09-30
Cilengitide in Treating Children With Refractory Primary Brain Tumors
National Cancer Institute (NCI)
Phase 1 Completed